Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

Jittamala P, Schilling WHK, Leopold SJ, Watson JA, Kotchum K, Wongnak P, Seers T, Asawasriworanan T, Singh S, Beer E, Ngernseng T, Suwannasin K, Madmanee W, Phommasone K, Shrestha S, de Aguiar RS, Batty EM, Teixeira MM, Karkey A, Ashley EA, Intalapaporn P, Luvira V, Phumratanaprapin W, Chotivanich K, Imwong M, White NJ, AD ASTRA Collaborative Group

Open source

DOI: 10.1016/s1473-3099(26)00255-0
Published: 2026 Jul 28
Container: The Lancet. Infectious diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00255-0,
  title = {Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.},
  author = {Jittamala P and Schilling WHK and Leopold SJ and Watson JA and Kotchum K and Wongnak P and Seers T and Asawasriworanan T and Singh S and Beer E and Ngernseng T and Suwannasin K and Madmanee W and Phommasone K and Shrestha S and de Aguiar RS and Batty EM and Teixeira MM and Karkey A and Ashley EA and Intalapaporn P and Luvira V and Phumratanaprapin W and Chotivanich K and Imwong M and White NJ and AD ASTRA Collaborative Group},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00255-0},
  url = {https://doi.org/10.1016/s1473-3099(26)00255-0}
}

RIS

TY  - JOUR
TI  - Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.
AU  - Jittamala P
AU  - Schilling WHK
AU  - Leopold SJ
AU  - Watson JA
AU  - Kotchum K
AU  - Wongnak P
AU  - Seers T
AU  - Asawasriworanan T
AU  - Singh S
AU  - Beer E
AU  - Ngernseng T
AU  - Suwannasin K
AU  - Madmanee W
AU  - Phommasone K
AU  - Shrestha S
AU  - de Aguiar RS
AU  - Batty EM
AU  - Teixeira MM
AU  - Karkey A
AU  - Ashley EA
AU  - Intalapaporn P
AU  - Luvira V
AU  - Phumratanaprapin W
AU  - Chotivanich K
AU  - Imwong M
AU  - White NJ
AU  - AD ASTRA Collaborative Group
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00255-0
UR  - https://doi.org/10.1016/s1473-3099(26)00255-0
ER  -

APA

P, J., WHK, S., SJ, L., JA, W., K, K., P, W., T, S., T, A., S, S., E, B., T, N., K, S., W, M., K, P., S, S., RS, D. A., EM, B., MM, T., A, K., EA, A., P, I., V, L., W, P., K, C., M, I., NJ, W., & Group, A. A. C. (2026). Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00255-0

Source records

pubmed · retrieved 2026-09-25T22:11:18.554Z